Chemed Corporation | Mid-cap | Healthcare
$430.02
-0.32%
| Chemed Stock Comparison:
Chemed vs HCA HealthcareChemed vs Tenet HealthcareChemed vs DaVitaChemed vs Option Care HealthChemed vs AmedisysChemed vs S&P 500 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Mar 2025

Income Metrics

Revenue 646.9M
Gross Profit 216.4M 33.45%
Operating Income 94.8M 14.65%
Net Income 71.8M 11.09%
EPS (Diluted) $4.86

Balance Sheet Metrics

Total Assets 1.7B
Total Liabilities 544.8M
Shareholders Equity 1.2B
Debt to Equity 0.46

Cash Flow Metrics

Operating Cash Flow 34.8M
Free Cash Flow 19.5M

Revenue & Profitability Trend

Chemed Income Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Revenue i 2.4B 2.3B 2.1B 2.1B 2.1B
Cost of Goods Sold i 1.6B 1.5B 1.4B 1.4B 1.4B
Gross Profit i 854.3M 798.8M 765.1M 769.8M 701.4M
Gross Margin % i 35.1% 35.3% 35.8% 36.0% 33.7%
Operating Expenses
Research & Development i - - - - -
Selling, General & Administrative i 424.4M 395.1M 358.7M 366.7M 330.2M
Other Operating Expenses i - - - - -75.1M
Total Operating Expenses i 424.4M 395.1M 358.7M 366.7M 255.1M
Operating Income i 366.9M 342.8M 347.2M 344.0M 389.7M
Operating Margin % i 15.1% 15.1% 16.3% 16.1% 18.7%
Non-Operating Items
Interest Income i 14.6M 6.3M 355.0K 377.0K 757.0K
Interest Expense i 1.8M 3.1M 4.6M 1.9M 2.4M
Other Non-Operating Income 19.7M 4.4M -13.3M 7.8M 8.7M
Pre-tax Income i 399.5M 350.4M 329.7M 350.3M 396.0M
Income Tax i 97.5M 77.9M 80.1M 81.8M 76.5M
Effective Tax Rate % i 24.4% 22.2% 24.3% 23.3% 19.3%
Net Income i 302.0M 272.5M 249.6M 268.6M 319.5M
Net Margin % i 12.4% 12.0% 11.7% 12.6% 15.4%
Key Metrics
EBITDA i 464.7M 416.6M 397.1M 412.2M 454.9M
EPS (Basic) i $20.10 $18.11 $16.72 $17.14 $20.02
EPS (Diluted) i $19.89 $17.93 $16.53 $16.85 $19.48
Basic Shares Outstanding i 15024000 15050000 14929000 15671000 15955000
Diluted Shares Outstanding i 15024000 15050000 14929000 15671000 15955000

Income Statement Trend

Chemed Balance Sheet From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Assets
Current Assets
Cash & Equivalents i 178.4M 264.0M 74.1M 32.9M 162.7M
Short-term Investments i - - - - -
Accounts Receivable i 171.2M 181.5M 139.4M 137.2M 126.9M
Inventory i 8.2M 12.0M 10.3M 10.1M 7.1M
Other Current Assets - - - - -
Total Current Assets i 394.7M 500.8M 272.6M 230.3M 329.4M
Non-Current Assets
Property, Plant & Equipment i 127.3M 126.4M 135.7M 125.0M 123.4M
Goodwill i 1.4B 1.3B 1.3B 1.3B 1.3B
Intangible Assets i 92.2M 90.3M 99.7M 108.1M 118.1M
Long-term Investments - - - - -
Other Non-Current Assets 137.5M 114.3M 102.2M 106.8M 186.4M
Total Non-Current Assets i 1.3B 1.2B 1.2B 1.1B 1.1B
Total Assets i 1.7B 1.7B 1.4B 1.3B 1.4B
Liabilities
Current Liabilities
Accounts Payable i 44.1M 48.3M 41.9M 73.0M 54.2M
Short-term Debt i 42.3M 54.3M 44.0M 37.9M 36.2M
Current Portion of Long-term Debt - - - - -
Other Current Liabilities 42.7M 36.3M 38.9M 39.0M 42.6M
Total Current Liabilities i 285.7M 312.0M 297.2M 302.4M 299.1M
Non-Current Liabilities
Long-term Debt i 98.5M 100.8M 203.0M 285.6M 99.2M
Deferred Tax Liabilities i 25.9M 30.3M 38.6M 23.2M 20.7M
Other Non-Current Liabilities 13.4M 13.0M 12.1M 9.6M 26.3M
Total Non-Current Liabilities i 263.9M 248.2M 346.1M 417.1M 234.6M
Total Liabilities i 549.6M 560.2M 643.3M 719.4M 533.7M
Equity
Common Stock i 37.4M 37.2M 36.8M 36.5M 36.3M
Retained Earnings i 2.7B 2.4B 2.2B 2.0B 1.7B
Treasury Stock i 3.1B 2.7B 2.6B 2.4B 1.8B
Other Equity - - - - -
Total Shareholders Equity i 1.1B 1.1B 798.7M 623.3M 901.2M
Key Metrics
Total Debt i 140.8M 155.1M 247.0M 323.5M 135.4M
Working Capital i 109.1M 188.8M -24.6M -72.1M 30.3M

Balance Sheet Composition

Chemed Cash Flow Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Operating Activities
Net Income i 302.0M 272.5M 249.6M 268.6M 319.5M
Depreciation & Amortization i 63.0M 60.9M 59.2M 59.1M 56.6M
Stock-Based Compensation i 32.0M 30.1M 26.3M 22.5M 18.4M
Working Capital Changes i 3.9M -39.4M -35.9M -20.3M 47.5M
Operating Cash Flow i 393.2M 319.5M 300.1M 306.2M 483.9M
Investing Activities
Capital Expenditures i 3.3M 640.0K 2.3M 904.0K 1.7M
Acquisitions i -97.4M -4.0M -3.5M 0 -3.6M
Investment Purchases i - - - - -
Investment Sales i - - - - -
Investing Cash Flow i -94.4M -3.8M -2.1M 918.0K -2.7M
Financing Activities
Share Repurchases i -361.4M -67.7M -114.5M -576.0M -175.6M
Dividends Paid i -27.1M -23.5M -22.0M -22.0M -21.1M
Debt Issuance i 0 0 100.0M 0 174.9M
Debt Repayment i 0 -97.5M -321.2M -25.3M -264.9M
Financing Cash Flow i -415.7M -182.0M -572.9M -441.8M -331.4M
Free Cash Flow i 368.0M 273.4M 252.6M 249.9M 430.5M
Net Change in Cash i -116.9M 133.7M -274.9M -134.7M 149.8M

Cash Flow Trend

Chemed Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 22.42
Forward P/E 17.52
Price to Book 5.28
Price to Sales 2.53
PEG Ratio -0.96

Profitability Ratios

Profit Margin 11.56%
Operating Margin 11.00%
Return on Equity 24.14%
Return on Assets 13.56%

Financial Health

Current Ratio 1.86
Debt to Equity 12.15
Beta 0.43

Per Share Data

EPS (TTM) $19.45
Book Value per Share $82.56
Revenue per Share $170.04

Peer Financial Comparison

Company Market Cap P/E Ratio P/B Ratio ROE Profit Margin Debt/Equity
che 6.4B 22.42 5.28 24.14% 11.56% 12.15
HCA Healthcare 100.2B 18.39 -81.31 13,631.68% 8.21% -37.45
Tenet Healthcare 17.7B 12.87 4.83 29.65% 7.18% 158.70
DaVita 9.4B 12.90 6.26 57.94% 6.35% 825.19
Option Care Health 4.5B 21.58 3.24 15.25% 3.93% 90.35
Amedisys 3.3B 39.30 2.69 6.67% 3.56% 35.34

Financial data is updated regularly. All figures are in the company's reporting currency.